Primary optimal cytoreduction | Neoadjuvant chemotherapy | p | |
---|---|---|---|
CA125 [IU/ml] | |||
Mean | 1206.79 | 2432.28 | |
Median | 190.7 | 600 | p = 0.000191 |
Range | (7.38-21442) | (49.22-22982) | |
HE4 [pmol/l] | |||
Mean | 78.87 | 602.45 | |
Median | 32.19 | 551.69 | p = 0.000004 |
Range | (2.5-775.79) | (45.82-1574.89) | |
YKL-40 [ng/ml] | |||
Mean | 108.13 | 203.96 | |
Median | 70.50 | 200.24 | p = 0.003991 |
Range | (16.42-417.27) | (45.02-437.01) | |
Cathepsin-L [ng/ml] | |||
Mean | 13.12 | 12.75 | |
Median | 12.64 | 11.05 | p = 0.5305 |
Range | (8.42-28.87) | (8.53-46.45) | |
bcl-2 [ng/ml] | |||
Mean | 20.86 | 22.75 | |
Median | 19.63 | 19.34 | p = 0.5741 |
Range | (17.52-24.19) | (4.88-81.02) |